Global Tourette Syndrome Drug Market Status and Outlook 2018-2025

August 2018 | 115 pages | ID: G0CB6EDC1B0EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Abide Therapeutics Inc
• Catalyst Pharmaceuticals Inc
• Neurocrine Biosciences Inc
• Psyadon Pharmaceuticals Inc
• Reviva Pharmaceuticals Inc
• Synchroneuron Inc
• Teva Pharmaceutical Industries Ltd
• Therapix Biosciences Ltd

Market by Type

• AZD-5213
• CPP-115
• Dutetrabenazine ER
• Ecopipam Hydrochloride
• Others

Market by Application

• Research Center
• Hospital
• Clinic
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Tourette Syndrome Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 AZD-5213
  3.1.2 CPP-115
  3.1.3 Dutetrabenazine ER
  3.1.4 Ecopipam Hydrochloride
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Research Center
  4.1.2 Hospital
  4.1.3 Clinic
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 AZD-5213 Production by Region
    6.1.1.2 CPP-115 Production by Region
    6.1.1.3 Dutetrabenazine ER Production by Region
    6.1.1.4 Ecopipam Hydrochloride Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Research Center Production by Region
    6.1.2.2 Hospital Production by Region
    6.1.2.3 Clinic Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 AZD-5213 Demand by Region
    6.2.1.2 CPP-115 Demand by Region
    6.2.1.3 Dutetrabenazine ER Demand by Region
    6.2.1.4 Ecopipam Hydrochloride Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Research Center Demand by Region
    6.2.2.2 Hospital Demand by Region
    6.2.2.3 Clinic Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Abide Therapeutics Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Catalyst Pharmaceuticals Inc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Neurocrine Biosciences Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Psyadon Pharmaceuticals Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Reviva Pharmaceuticals Inc
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Synchroneuron Inc
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Teva Pharmaceutical Industries Ltd
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Therapix Biosciences Ltd
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Tourette Syndrome Drug Industry Dynamics & Regulations List
Table Global Tourette Syndrome Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Tourette Syndrome Drug Market Status by Type 2015-2018E, in USD Million
Table Global Tourette Syndrome Drug Market Status by Application 2015-2018E, in USD Million
Table Global Tourette Syndrome Drug Market Status by Application 2015-2018E, in Volume
Table Global Tourette Syndrome Drug Market by Region 2015-2018E, in USD Million
Table Global Tourette Syndrome Drug Market Share by Region in 2018, in USD Million
Table Global Tourette Syndrome Drug Market by Region 2015-2018E, in Volume
Table Global Tourette Syndrome Drug Market Share by Region in 2018, in Volume
Table AZD-5213 Production Value by Region 2015-2018E, in USD Million
Table AZD-5213 Production Volume by Region 2015-2018E, in Volume
Table CPP-115 Production Value by Region 2015-2018E, in USD Million
Table CPP-115 Production Volume by Region 2015-2018E, in Volume
Table Dutetrabenazine ER Production Value by Region 2015-2018E, in USD Million
Table Dutetrabenazine ER Production Volume by Region 2015-2018E, in Volume
Table Ecopipam Hydrochloride Production Value by Region 2015-2018E, in USD Million
Table Ecopipam Hydrochloride Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Research Center Production Value by Region 2015-2018E, in USD Million
Table Research Center Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table AZD-5213 Market Size by Region 2015-2018E, in USD Million
Table AZD-5213 Market Size by Region 2015-2018E, in Volume
Table CPP-115 Market Size by Region 2015-2018E, in USD Million
Table CPP-115 Market Size by Region 2015-2018E, in Volume
Table Dutetrabenazine ER Market Size by Region 2015-2018E, in USD Million
Table Dutetrabenazine ER Market Size by Region 2015-2018E, in Volume
Table Ecopipam Hydrochloride Market Size by Region 2015-2018E, in USD Million
Table Ecopipam Hydrochloride Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Research Center Market Size by Region 2015-2018E, in USD Million
Table Research Center Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalTourette Syndrome Drug Forecast by Type 2019F-2025F, in USD Million
Table Tourette Syndrome Drug Forecast by Type 2019F-2025F, in Volume
Table Tourette Syndrome Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Tourette Syndrome Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Tourette Syndrome Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Tourette Syndrome Drug Market Forecast by Region 2019F-2025F, in Volume
Table Abide Therapeutics Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Abide Therapeutics Inc
Table Catalyst Pharmaceuticals Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Catalyst Pharmaceuticals Inc
Table Neurocrine Biosciences Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Neurocrine Biosciences Inc
Table Psyadon Pharmaceuticals Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Psyadon Pharmaceuticals Inc
Table Reviva Pharmaceuticals Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Reviva Pharmaceuticals Inc
Table Synchroneuron Inc Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Synchroneuron Inc
Table Teva Pharmaceutical Industries Ltd Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd
Table Therapix Biosciences Ltd Information
Table Tourette Syndrome Drug Sales, Cost, Margin of Therapix Biosciences Ltd
Table Global Tourette Syndrome Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Tourette Syndrome Drug Sales Volume by Company 2015-2017, in Volume
Table Global Tourette Syndrome Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Tourette Syndrome Drug Picture
Figure Tourette Syndrome Drug Industry Chain Diagram
Figure Global Tourette Syndrome Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Tourette Syndrome Drug Sales Volume 2015-2018E, in Volume
Figure Global Tourette Syndrome Drug Market Status by Type 2015-2018E, in Volume
Figure North America Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Tourette Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Tourette Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Tourette Syndrome Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Tourette Syndrome Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Tourette Syndrome Drug Sales Price Forecast 2019F-2025F
Figure Global Tourette Syndrome Drug Gross Margin Forecast 2019F-2025F
Figure Global Tourette Syndrome Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Tourette Syndrome Drug Price by Company in 2018
Figure Global Tourette Syndrome Drug Gross Margin by Company in 2018